Skip to Main Navigation Skip to Main Content Skip to Footer

The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.

  • About Stem Cells
  • Donate
  • Join

The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.

  • About ISSCR
    • History & Philosophy
    • ISSCR Leadership
      • Officers & Board of Directors
      • ISSCR Committees
    • ISSCR Staff
    • Awards
      • ISSCR Outstanding Young Investigator Award
      • ISSCR Achievement Award
      • ISSCR Momentum Award
      • Public Service Award
      • Zhongmei Chen Yong Awards for Scientific Excellence
      • Poster Awards
      • Merit Abstract Awards
      • ISSCR Tobias Award Lecture
      • ISSCR Award for Innovation
    • Circle of Stem Cell Institute and Center Directors
    • Donate
    • Contact Us
  • Membership
    • Join or Renew
    • Update Your Profile
    • Member Spotlight
    • Nominations for the Board of Directors
    • 2022 Election Results
  • Meetings & Events
    • Annual Meetings
      • About Annual Meetings
      • ISSCR Annual Meeting 2023
      • ISSCR Annual Meeting 2022
    • International Symposia
      • About International Symposia
      • Madison 2022 Symposium
      • Boston 2022 Symposium
    • ISSCR Digital
      • About ISSCR Digital
      • Spatial Transcriptomics
      • Cellular Barcoding
      • Speaker's Corner
    • Non-ISSCR Meetings & Courses
    • Code of Conduct for ISSCR Meetings and Events
  • Policy & Advocacy
    • Guidelines
    • Lawrence Goldstein Science Policy Fellowship Program
    • Positions and Statements
    • Annual Advocacy Day
  • News & Publications
    • Stem Cell Reports
      • Journal Homepage
      • Editors
      • Editorial Board
    • Podcast - The Stem Cell Report
    • ISSCR News Digital Newsletter
    • Press Releases/Statements
    • Stem Cells in Focus - Blog
    • News from ISSCR
    • Advertise with the ISSCR
    • Early Career Scientist Editorial Board
  • Careers
    • Job Board
    • Jobs with the ISSCR
    • Career Development Videos
    • Funding Resources
    • Women in Science
  • Resources
    • Scientific Resources
    • Clinical Resources
    • Education Resources
    • Patient Resources
    • Stem Cell Institutes and Centers
    • COVID-19 Resources for the Stem Cell Community
      • Covid 19 Networking & Meetings
    • ISSCR COVID-19 Survey Results
  • Home
  • News & Publications
  • News Articles
  • Member News Items
  • Policy News
  • Press Releases/Statements
      • 8 April, 2019

    Guidelines and Regulations Necessary as Stem Cell Field Advances

    With the rapid growth of the stem cell field and advances in regenerative medicine, it is critically important that researchers earn and retain the public trust. To that end we must operate under agreed-upon guidelines that ensure ethical activities, transparency, and sound science.
    Full story
      • 29 March, 2019

    ISSCR Comments on New Biomedical Technology Regulations in China

    In response to draft regulations in China on gene editing and other potentially risky biomedical technologies, the ISSCR has submitted comments to the the country's National Health Commission Medical and Medical Administration Bureau.
    Full story
      • 13 March, 2019

    ISSCR Applauds New Japanese Rules Allowing Human-to-Animal Chimeric Embryo Research

    The ISSCR supports research using human-animal chimeras conducted under appropriate review and oversight (ISSCR Guidelines Recommendation 2.1.5) and applauds the new Japanese rules enabling research on chimeric embryos.
    Full story
      • 22 February, 2019

    Advocating for Science and Research

    Scientists play a critical role in advocating for research that is advancing healthcare and biomedicine. In the February edition of Stem Cell Reports, several ISSCR researchers share their answers to the question 'Why is it important to you to support fetal tissue research?'
    Full story
      • 13 December, 2018

    ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research

    In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
    Full story
      • 26 November, 2018

    ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment

    Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.
    Full story
      • 21 November, 2018

    ISSCR Comments to FDA Regarding ClinicalTrials.gov

    In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."
    Full story
      • 16 November, 2018

    ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable

    The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.
    Full story
      • 16 October, 2018

    ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research

    The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.
    Full story
      • 2 October, 2018

    ISSCR Comments on Horizon Europe

    The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020.
    Full story
      • 2 October, 2018

    ISSCR Voice is Heard on Capitol Hill

    In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services but did not include a ban on federal funding for fetal tissue research. ISSCR treasurer Arnold Kriegstein visited Senate and House leaders and staff on Capitol Hill shortly after the vote to voice appreciation for the Senate effort.
    Full story
      • 27 September, 2018

    ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research

    The ISSCR is troubled by the HHS decision to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue.
    Full story
      • 14 June, 2018

    ISSCR Opposes Proposal to Restrict Fetal Tissue Research

    The ISSCR opposes the U.S. House of Representatives proposal to ban federal funding for fetal tissue research. ISSCR President Hans Clevers released a statement on the issue.
    Full story
      • 4 June, 2018

    ISSCR Responds to President Trump Signing 'Right to Try' Law

    The ISSCR is disappointed with the enactment of the ‘Right to Try’ law. Along with more than 100 patient and research groups opposing the bill, we believe it will put patients at risk and undermine the effective FDA Expanded Access Program already in place to give seriously ill patients access to experimental treatments.
    Full story
      • 10 May, 2018

    ISSCR Applauds Federal Injunctions Against Stem Cell Clinics

    The ISSCR is pleased that federal prosecutors in the U.S. have taken action to halt the marketing and delivery of unproven stem cell treatments at clinics they allege are operating outside of FDA regulation.
    Full story
    • 1
    • 2
    • 3
    • 4 (current)
    • 5
    • 6
    • 7
  • About ISSCR
    • History & Philosophy
    • ISSCR Leadership
    • ISSCR Staff
    • Awards
    • Circle of Stem Cell Institute and Center Directors
    • Donate
    • Contact Us
  • Membership
    • Join or Renew
    • Update Your Profile
    • Member Spotlight
    • Nominations for the Board of Directors
    • 2022 Election Results
  • Meetings & Events
    • Annual Meetings
    • International Symposia
    • ISSCR Digital
    • Non-ISSCR Meetings & Courses
    • Code of Conduct for ISSCR Meetings and Events
  • Policy & Advocacy
    • Guidelines
    • Lawrence Goldstein Science Policy Fellowship Program
    • Positions and Statements
    • Annual Advocacy Day
  • News & Publications
    • Stem Cell Reports
    • Podcast - The Stem Cell Report
    • ISSCR News Digital Newsletter
    • Press Releases/Statements
    • Stem Cells in Focus - Blog
    • News from ISSCR
    • Advertise with the ISSCR
    • Early Career Scientist Editorial Board
  • Careers
    • Job Board
    • Jobs with the ISSCR
    • Career Development Videos
    • Funding Resources
    • Women in Science
  • Resources
    • Scientific Resources
    • Clinical Resources
    • Education Resources
    • Patient Resources
    • Stem Cell Institutes and Centers
    • COVID-19 Resources for the Stem Cell Community
    • ISSCR COVID-19 Survey Results
Privacy Policy | Terms of Use
The International Society for Stem Cell Research | Phone: +1 (224) 592-5700 | Email: isscr@isscr.org
©2019 The International Society for Stem Cell Research. All rights reserved.

Connect with Us

  • Twitter
  • Facebook
  • LinkedIn
  • YouTube
  • LinkedIn
  • Podcast